Clinical trials
Phase 3 Lymphoma trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
| Completed | 7 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Genmab | 2 |
| Janssen Research & Development, LLC | 2 |
| Loxo Oncology, Inc. | 2 |
| ADC Therapeutics S.A. | 1 |
| Acerta Pharma BV | 1 |
| Bristol-Myers Squibb | 1 |
| Japan Clinical Oncology Group | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 15 |
| Lymphoma, Non-Hodgkin | 6 |
| Lymphoma, B-Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Follicular | 3 |
| Neoplasms | 3 |
| Hematologic Diseases | 2 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.